G GILD

Gilead Sciences Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Gilead Sciences, Inc. is a leading biopharmaceutical company based in Foster City, California, renowned for its pioneering advancements in antiviral therapeutics, especially for HIV and hepatitis. The company's innovative treatments, such as Harvoni and Sovaldi, have fundamentally transformed the ma...

$170.68

+3.06% (+$5.07)

Volume 11.36M

52W High $175.65

52W Low $114.02

Market Cap $201.46B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Oct 29, 2026 Beat

Actual: $2.55 vs. Consensus: $2.17

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q3 2026 Oct 29, 2026

1-Day: +3.06%

Q2 2026 Aug 4, 2026

1-Day: -2.58%

Q2 2026 Aug 3, 2026

1-Day: +3.13%

Q1 2026 May 7, 2026

1-Day: -2.04%

5-Day: +0.66%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'26	$8.30B	+6.8%	81.1%	41.7%	$2.43B
Q2'26	$7.80B	+10.2%	79.8%	-133.2%	-$10.50B
Q1'26	$6.96B	+4.4%	79.2%	38.7%	$2.02B
Q4'25	$7.92B	+4.7%	79.5%	37.7%	$2.18B
Q3'25	$7.77B	+3.0%	79.8%	42.8%	$3.05B
Q2'25	$7.08B	+1.8%	78.8%	34.9%	$1.96B
Q1'25	$6.67B	-0.3%	76.9%	33.6%	$1.32B
Q4'24	$7.57B	+6.4%	79.1%	32.4%	$1.78B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Oct 29, 2026	$2.17	$2.50	$2.55	+17.51%	Beat
Q2 2026	Aug 4, 2026	-$7.07	-$7.07	$2.01	--	Beat
Q2 2026	Aug 3, 2026	-$7.07	-$7.07	-$6.75	+4.53%	Beat
Q1 2026	May 7, 2026	$1.91	$1.79	$2.03	+6.28%	Beat
Q1 2026	Apr 23, 2026	$1.89	$1.96	$2.03	+7.41%	Beat
Q4 2025	Feb 10, 2026	$1.81	$1.90	$1.86	+2.76%	Missed
Q3 2025	Oct 30, 2025	$2.14	$2.32	$2.47	+15.42%	Beat
Q2 2025	Aug 7, 2025	$1.95	$2.15	$2.01	+3.08%	Missed
Q1 2025	May 8, 2025	$1.77	$1.94	$1.81	+2.11%	Missed
Q1 2025	Apr 24, 2025	$1.78	$1.94	$1.81	+1.69%	Missed
Q4 2024	Feb 11, 2025	$1.70	$1.88	$1.90	+11.73%	Met
Q4 2024	Feb 4, 2025	$1.70	$1.85	$1.90	+11.73%	Beat